The Enterprise Value as of December 2025 (TTM) for TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) is 8.13B

According to TaiGen Biopharmaceuticals Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 8.13B. This represents a change of -3.05% compared to the average of 8.38B of the last 4 quarters.

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Historical Enterprise Value (quarterly & annually)

How has 4157.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of TaiGen Biopharmaceuticals Holdings Limited over the last ten years is 14.02B. The current 8.13B Enterprise Value has changed 5.70% with respect to the historical average. Over the past ten years (40 quarters), 4157.TWO's Enterprise Value was at its highest in in the December 2015 quarter at 22.74B. The Enterprise Value was at its lowest in in the June 2025 quarter at 6.71B.

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of TaiGen Biopharmaceuticals Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Average Enterprise Value

How has 4157.TWO Enterprise Value performed in the past?

The current Enterprise Value of TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Enterprise Value vs. Peers

How is 4157.TWO’s Enterprise Value compared to its peers?

TaiGen Biopharmaceuticals Holdings Limited’s Enterprise Value is greater than Pharmosa Biopharm Inc. (6.30B), greater than OBI Pharma, Inc. (6.99B), greater than Mycenax Biotech Inc. (7.51B), greater than CHO Pharma, Inc. (6.48B), greater than Sinphar Pharmaceutical Co.,Ltd. (6.61B), less than Adimmune Corporation (9.19B), greater than BioGend Therapeutics Co., Ltd. (4.66B), greater than Panion & Bf Biotech Inc. (5.87B), greater than Savior Lifetec Corporation (4.69B), less than Locus Cell Co., Ltd. (0),

Build a custom stock screener for TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiGen Biopharmaceuticals Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TaiGen Biopharmaceuticals Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.